North Star Investment Management’s Altimmune ALT Stock Holding History

North Star Investment Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.9K	Buy	22,000 +5,000	+29%	+$14.9K	﹤0.01%	686
2026 Q1	$52.4K	Buy	17,000 +9,000	+113%	+$38.2K	﹤0.01%	725
2025 Q4	$28.9K	Hold	8,000	–	–	﹤0.01%	788
2025 Q3	$30.2K	Sell	8,000 -9,000	-53%	-$34.8K	﹤0.01%	756
2025 Q2	$65.8K	Sell	17,000 -13,000	-43%	-$70.4K	﹤0.01%	587
2025 Q1	$150K	Hold	30,000	–	–	0.01%	452
2024 Q4	$216K	Buy	30,000 +15,900	+113%	+$121K	0.02%	404
2024 Q3	$86.6K	Buy	14,100 +1,000	+8%	+$6.78K	0.01%	525
2024 Q2	$87.1K	Buy	13,100 +10,100	+337%	+$74.5K	0.01%	520
2024 Q1	$30.5K	Buy	+3,000	New	+$30.5K	﹤0.01%	683
2017 Q3	–	Sell	-3	Closed	–	–	1081
2017 Q2	$0	Hold	3	–	–	﹤0.01%	1074
2017 Q1	$1K	Hold	3	–	–	﹤0.01%	1001
2016 Q4	$3K	Buy	+3	New	+$2.69K	﹤0.01%	871

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

North Star Investment Management's ALT Position: Q2 2026 in Review

North Star Investment Management increased its Altimmune (ALT) stake by 29% in Q2 2026, buying an estimated $14.9K and bringing the position to 22,000 shares worth $66.9K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

North Star Investment Management first reported a position in ALT in Q4 2016 and has held it in 13 quarters since. The position peaked at $216K in Q4 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

North Star Investment Management held 22,000 shares of Altimmune worth $66.9K as of Q2 2026.
North Star Investment Management bought 5,000 Altimmune shares in Q2 2026, an estimated $14.9K.
Altimmune made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #686 holding.
North Star Investment Management first reported a position in Altimmune in Q4 2016 and has held it in 13 quarters since.
North Star Investment Management's Altimmune position peaked at $216K in Q4 2024.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.